Skip to main content
. 2021 Jan 11;20:17. doi: 10.1186/s12933-021-01213-w

Fig. 1.

Fig. 1

Meta-analysis evaluating the efficacy of SGLT-2i (empagliflozin, canagliflozin and dapagliflozin) on MACE according to basal eGFR values in four trials (EMPA-REG, CANVAS, DECLARE and CREDENCE)